Cougar Biotechnology, Inc.

Rights licensed for Emory University's noscapine patent portfolio

Published in Law and Health Weekly, July 17th, 2004

Cougar Biotechnology, Inc., a privately held biotechnology company, announced that it has licensed the worldwide, exclusive rights to Emory's intellectual property portfolio for noscapine and analogs of noscapine.

In 1998, Harish Joshi, PhD, professor of cell biology at Emory University School of Medicine, and his colleagues discovered that noscapine, an opium alkaloid that has been used as an antitussive agent in Japan, Sweden, and South Africa, has potent antitumor activity against solid murine lymphoid tumors and against human breast and bladder tumors implanted in nude mice.

Noscapine was found to bind stoichiometrically to tubulin and affect...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2004-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry